Contact this trialFirst, we need to learn more about you.
Metal Complex
Gallium Maltolate for Glioblastoma
Recruiting1 awardPhase 1
Milwaukee, Wisconsin
This trial is testing an oral medicine called gallium maltolate in patients with brain cancer that has come back after treatment. The goal is to see if the medicine can safely stop the growth of cancer cells. Gallium maltolate has shown potential in slowing the growth of glioblastoma by disrupting iron metabolism and inhibiting mitochondrial function.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service